Immuno-GPCRs in Focus: Categorization, Functional Mechanisms, and Assays for Intracellular Pathway Analysis

G Protein Coupled Receptors (GPCRs) represent a vast and diverse family of membrane proteins that are central to the regulation of human immune cell function. These receptors mediate responses to a wide array of external signals and play pivotal roles in the migration, activation, and coordination of immune cells in both innate and adaptive immunity. This review will explore the multifaceted roles of GPCRs in immunity by focusing on the distinct functional subsets involved, elucidating the key signaling pathways they engage, and examining their expression and functions across different immune cell types including T cells, macrophages, and dendritic cells.

GPCRs

The human genome encodes about 800 G protein-coupled receptors (GPCRs). GPCRs are grouped into several main classes: Class A (Rhodopsin-like), the largest and most studied, responds to neurotransmitters, peptide hormones, and sensory signals; Class B (Secretin and Adhesion) mediates peptide hormone signaling and cell adhesion; Class C (Glutamate-like) regulates neurotransmission via amino acid ligands; and Class F (Frizzled/Smoothened) participates in developmental Wnt and Hedgehog pathways. These receptors recognize a wide array of ligands, including amines, peptides, proteins, lipids, nucleotides, ions, and sensory stimuli such as light and odorants. Serving as key regulators of processes such as cardiovascular function, immune responses, neurotransmission, and metabolism, GPCRs are vital to human health, and their dysregulation or mutation is linked to diseases spanning cardiovascular, neurological, metabolic, psychiatric, and cancerous conditions, making them the most targeted protein family in modern therapeutics.

Immuno-GPCRs

In humans, more than 100 GPCRs participate directly in immune modulation. These receptors are expressed across diverse immune cell types and orchestrate key processes such as migration, activation, differentiation, and cytokine secretion. Functionally, they include chemokine receptors that direct leukocyte trafficking, lipid-sensing receptors for mediators like prostaglandins and sphingosine-1-phosphate, purinergic receptors responsive to extracellular nucleotides and nucleosides, complement receptors that integrate signals from the complement cascade, formyl peptide receptors that detect bacterial products, adhesion GPCRs involved in cell-cell and cell-matrix interactions, and protease-activated receptors that respond to proteolytic cleavage.

Their ligands span several biochemical families: chemokines, bioactive lipids, nucleotides and nucleosides, peptides and proteins (including microbial signals), complement fragments, and various extracellular matrix–derived or pathogen-associated metabolites. Through these interactions, GPCRs guide immune cells to sites of infection or injury, regulate the balance between pro- and anti-inflammatory responses, and maintain immune homeostasis.

Aberrations in GPCR signaling contribute to a spectrum of diseases, from chronic inflammation and autoimmunity to cancer, allergy, and infection susceptibility. By integrating extracellular cues into coordinated cellular responses, GPCRs form a central communication network that underpins effective immune surveillance and the resolution of inflammation in human health and disease.

GPCR Signaling Pathways in Immune Cells

GPCR activation triggers multiple intracellular signaling cascades through coupling with distinct G proteins, enabling fine-tuned cellular responses:

• The cAMP pathway, mediated mainly via Gs and Gi proteins, regulates cyclic AMP levels, influencing gene transcription and cellular metabolism. In immune cells, cAMP often acts as an immunomodulatory signal, dampening excessive inflammation.
• The phosphatidylinositol (PI) pathway through Gq proteins leads to activation of phospholipase C, generating second messengers IP3 and DAG, resulting in calcium mobilization and protein kinase C activation crucial for cell activation and cytokine production.
• The beta-gamma (βγ) subunit pathway released upon GPCR activation influences ion channels, kinases, and other signaling molecules, modulating chemotaxis, survival, and respiratory burst activities.
• The Rho pathway, via G12/13 proteins, regulates cytoskeletal dynamics and cellular morphology, essential for migration and phagocytosis.
• The MAP kinase pathway, often downstream of βγ subunits or other intermediates, controls gene expression related to proliferation, differentiation, and inflammatory mediator production.

Table 1.  Signaling pathways of GPCR subsets involved in immune modulation

GPCR Function in Different Immune Cell Types

GPCR subsets and signaling pathways across immune cells tailor immune responses:

• In T cell subset including regulatory T cells (Tregs), cytotoxic T lymphocytes (CTLs), and helper T cells (Th1, Th2, Th17), GPCRs modulate migration, cytokine production, and effector functions. For example, chemokine receptors direct T cell trafficking to lymphoid and inflamed tissues, while prostaglandin receptors can suppress or enhance T cell activation depending on the context. Lysophospholipid receptors influence T cell egress from lymphoid organs, and purinergic receptors modulate T cell survival and differentiation.
• In macrophages, GPCRs such as formyl peptide receptors and complement receptors enhance pathogen recognition and phagocytosis. Prostaglandin and leukotriene receptors regulate the balance between pro- and anti-inflammatory states, guiding macrophage polarization and tissue repair functions. The Rho pathway influences macrophage motility and phagocytic capacity.
• In dendritic cells, chemokine and lysophospholipid receptors govern migration to lymph nodes, crucial for antigen presentation and T cell priming. Purinergic and protease-activated receptors modulate dendritic cell maturation and cytokine secretion, impacting adaptive immunity initiation.
• In granulocytes, GPCRs regulate key granulocyte functions such as generating reactive oxygen species and activating proteolytic enzymes, which are critical for their cytotoxic response. GPCRs also control granulocyte migration by directing chemotaxis and cell polarization through pathways that influence movement and adhesion. For example, the chemokine receptor family (such as CXCR1 and CXCR2) guides granulocyte migration toward infection sites, while formyl peptide receptors (FPRs) detect microbial peptides to stimulate reactive oxygen species production and bacterial clearance. These signaling pathways also regulate granulocyte gene expression and survival, affecting their differentiation and functional state.

Pathways and Assays for GPCR Signaling in Immune Cells

GPCRs represent one of the most versatile and pharmacologically important receptor families, acting as critical sentinels that translate extracellular signals into diverse intracellular responses. In the immune system, GPCRs orchestrate fundamental processes including migration, activation, cytokine release, and effector function, by engaging distinct downstream signaling pathways. Understanding these pathways is particularly important for T cells, macrophages, dendritic cells, and granulocytes, where GPCR-mediated signaling fine-tunes immunity and maintains balance between protective responses and excessive inflammation. Commercially available assays targeting cAMP, calcium flux, Gβγ signaling, Rho activation, and MAP kinase cascades have enabled precise dissection of these pathways, providing powerful tools to uncover cellular mechanisms and accelerate drug discovery. The following sections summarize the key GPCR signaling branches in immune cells, the functional outcomes they regulate, and the standard assays used to measure their activity.

Pathway: cAMP (Gs / Gi)

GPCR (Gs/Gi) → ↑ or ↓ cAMP → PKA activation → transcriptional changes

Immune cell roles:

• T cells: restrains proliferation and activation
• Macrophages/Dendritic cells: reduces pro-inflammatory cytokine release
• Granulocytes: suppresses degranulation, ROS production

Assays: cAMP HTRF kits, BRET/FRET biosensors, luminescent CRE-luciferase reporters

Pathway: Phosphatidylinositol (Gq → PLC → IP3/DAG)

GPCR (Gq) → PLCβ activation → IP3 + DAG → ↑ Ca²⁺ + PKC

Immune cell roles:

• T cells: calcium flux drives activation, IL-2 secretion
• Macrophages/Dendritic cells: regulates cytokine production, antigen presentation
• Granulocytes: triggers degranulation, oxidative burst

Assays: Calcium-sensitive dyes (Fluo-4, Indo-1), luciferase under Ca²⁺-responsive promoters

Pathway: Gβγ Subunit Signaling

GPCR (βγ release) → modulation of ion channels, PI3K, kinases

Immune cell roles:

• T cells: regulates survival and chemotaxis
• Macrophages/Dendritic cells: directed migration to chemokines
• Granulocytes: key for chemotaxis and ROS generation

Assays: GIRK ion channel readouts, BRET/FRET-based kinase recruitment, chemotaxis chambers

Pathway: Rho (G12/13)

GPCR (G12/13) → RhoGEFs → RhoA activation → cytoskeletal changes

Immune cell roles:

• T cells: cytoskeletal reorganization, immunological synapse formation
• Macrophages/Dendritic cells: phagocytosis, motility
• Granulocytes: extravasation, adhesion during inflammation

Assays: Rho-GTP pulldowns, FRET Rho sensors, label-free impedance-based cell migration/morphology assays

Pathway: MAP Kinase (ERK, JNK, p38)

GPCR → βγ or intermediates → MAPK cascade → gene expression changes

Immune cell roles:

• T cells: proliferation, differentiation (Th1/Th2 polarization)
• Macrophages/Dendritic cells: control of cytokine gene expression, inflammatory mediator production
• Granulocytes: survival, priming, cytokine release, degranulation

Assays: phospho-ERK/p38 ELISAs, western blotting, MAPK-responsive luciferase reporters

Conclusion

Taken together, GPCR signaling pathways illustrate the remarkable versatility with which immune cells interpret and respond to environmental cues. By coupling to distinct G proteins and second messenger systems, GPCRs enable T cells, macrophages, dendritic cells, and granulocytes to finely modulate proliferation, migration, cytoskeletal dynamics, cytokine production, and effector function. The availability of robust commercial assays for each pathway has not only advanced our mechanistic understanding of leukocyte biology but also provided vital platforms for therapeutic discovery, where modulation of GPCR activity holds promise for controlling inflammation, enhancing host defense, or dampening autoimmunity. In this way, mapping GPCR signaling in immune cells bridges fundamental immunology with clinical applications, reinforcing their central role as both biological regulators and drug targets.